Sattva S. Neelapu
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Moffitt Cancer Center(US)Allogene Therapeutics (United States)(US)Scripps MD Anderson Cancer Center(US)Anderson University - South Carolina(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses
Most-Cited Works
- → Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma(2017)5,738 cited
- → ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells(2018)3,224 cited
- → Chimeric antigen receptor T-cell therapy — assessment and management of toxicities(2017)2,299 cited
- → Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial(2018)2,184 cited
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study(2017)1,636 cited